Clinical trials represent a significant ... amounts of genomics and biomarker data and not only identify predictive factors for efficacy, but also set thresholds to optimize segmentation of ...

With the increasing adoption of COAs, the importance of standardization across training, collection, and implementation to ensure high quality and consistent data collection has become apparent in ...

ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage ... the final full data set from its multiple ascending dose clinical trial for AL001 treatment ...

Dyne Therapeutics is set to report new clinical data from its Phase 1/2 ACHIEVE clinical trial, which could positively impact investor confidence and interest. The upcoming webcast and press ...